A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation
In conclusion,DMG, H3 K27 and BRAF/FGFR1 co-altered represent a new subtype of DMG with distinct genotype/phenotype characteristics, which deserve further attention with respect to trial interpretation and patient management.
Source: Acta Neuropathologica - Category: Neurology Source Type: research
More News: Astrocytoma | Brain | Brain Tumor | Cancer & Oncology | Glioma | Neurology | Pediatrics | Study